IMPA1 and cancer: Notably, for those proteins such as IdeS from Group A Streptococcus(GAS) and ImpA from Pseudomonas aeruginosa, an innovative synergistic EV-based strategy aimed for more effective cancer therapy is further conceived based on their additional functions concerning tumor targeting or deactivation.